国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2015年
15期
2224-2225
,共2页
类风湿性关节炎%25-羟维生素D%维生素D
類風濕性關節炎%25-羥維生素D%維生素D
류풍습성관절염%25-간유생소D%유생소D
rheumatoidarthritis%25-hydroxyvitaminD%vitaminD
目的:观察类风湿性关节炎(RA )患者血清25‐羟维生素D [25‐(O H )D ]水平变化,并研究其临床意义。方法采用化学发光法检测60例RA患者(RA组)与60例健康人(对照组)外周血血清25‐(O H )D。结果 RA组血清25‐(O H )D水平为(34.37±8.87)nmol/L ,对照组为(61.33±7.74)nmol/L ,两组比较差异有统计学意义(t=-6.892,P<0.05),RA患者血清25‐(OH)D水平与RA患者年龄、体质量指数(BMI)、晨僵时间、关节压痛数(TJC)、关节肿胀数(SJC)、C反应蛋白(CRP)、红细胞沉降率(ESR)、疾病总体疼痛(VAS)评分、生活质量(HAQ)评分以及疾病活动度(DAS28)评分呈负相关(r=-0.201、-0.255、-0.362、-0.296、-0.273、-0.198、-0.323、-0.356、-0.379、-0.418,P<0.05);与病程、类风湿因子(RF )、抗环瓜氨酸肽(CCP)抗体滴度等无相关性(P>0.05)。结论 RA患者血清25‐(OH)D水平明显低下,与RA疾病活动度相关。
目的:觀察類風濕性關節炎(RA )患者血清25‐羥維生素D [25‐(O H )D ]水平變化,併研究其臨床意義。方法採用化學髮光法檢測60例RA患者(RA組)與60例健康人(對照組)外週血血清25‐(O H )D。結果 RA組血清25‐(O H )D水平為(34.37±8.87)nmol/L ,對照組為(61.33±7.74)nmol/L ,兩組比較差異有統計學意義(t=-6.892,P<0.05),RA患者血清25‐(OH)D水平與RA患者年齡、體質量指數(BMI)、晨僵時間、關節壓痛數(TJC)、關節腫脹數(SJC)、C反應蛋白(CRP)、紅細胞沉降率(ESR)、疾病總體疼痛(VAS)評分、生活質量(HAQ)評分以及疾病活動度(DAS28)評分呈負相關(r=-0.201、-0.255、-0.362、-0.296、-0.273、-0.198、-0.323、-0.356、-0.379、-0.418,P<0.05);與病程、類風濕因子(RF )、抗環瓜氨痠肽(CCP)抗體滴度等無相關性(P>0.05)。結論 RA患者血清25‐(OH)D水平明顯低下,與RA疾病活動度相關。
목적:관찰류풍습성관절염(RA )환자혈청25‐간유생소D [25‐(O H )D ]수평변화,병연구기림상의의。방법채용화학발광법검측60례RA환자(RA조)여60례건강인(대조조)외주혈혈청25‐(O H )D。결과 RA조혈청25‐(O H )D수평위(34.37±8.87)nmol/L ,대조조위(61.33±7.74)nmol/L ,량조비교차이유통계학의의(t=-6.892,P<0.05),RA환자혈청25‐(OH)D수평여RA환자년령、체질량지수(BMI)、신강시간、관절압통수(TJC)、관절종창수(SJC)、C반응단백(CRP)、홍세포침강솔(ESR)、질병총체동통(VAS)평분、생활질량(HAQ)평분이급질병활동도(DAS28)평분정부상관(r=-0.201、-0.255、-0.362、-0.296、-0.273、-0.198、-0.323、-0.356、-0.379、-0.418,P<0.05);여병정、류풍습인자(RF )、항배과안산태(CCP)항체적도등무상관성(P>0.05)。결론 RA환자혈청25‐(OH)D수평명현저하,여RA질병활동도상관。
Objective To observe the changes of serum 25‐hydroxy vitamin D[25‐(OH)D] level of patients with rheumatoid ar‐thritis(RA) and study its clinical significance .Methods The method of chemiluminescence was adopted to detect peripheral blood serum 25‐(OH) D of 60 cases of RA patients(RA group) and 60 cases of healthy people(control group) .Results The serum 25‐(OH) D level of patients in RA group was(34 .37 ± 8 .87) nmol/L ,while that of the control group was(61 .33 ± 7 .74) nmol/L ;after comparison ,the differences were statistically significant (t= -6 .892 ,P< 0 .05);the serum 25‐(OH) D level of patients in RA group was in negative correlation with RA patient age ,body mass index(BMI) ,time of morning stiffness ,tender joint count(TJC) , swollen joint count(SJC) ,C‐reactive protein(CRP) ,erythrocyte sedimentation rate(ESR) ,visual analog scale(VAS) for disease o‐verall pain and health assessment questionnaire (HAQ) and disease activity score (DAS28)(r= -0 .201 ,-0 .255 ,-0 .362 ,-0 .296 ,-0 .273 ,-0 .198 ,-0 .323 ,-0 .356 ,-0 .379 ,-0 .418 ;P<0 .05 in all cases);but had no correlation with course of dis‐ease ,rheumatoid factor (RF) ,anti‐cyclic citrullinated peptide (CCP) antibody (anti‐CCP) and antibody concentration (P> 0 .05) . Conclusion The serum 25‐(OH) D level of RA patients is significantly low ,which might be associated with the RA disease activi‐ty .